Purpose: The purpose of this study was to assess the relationship between donor factors and 5-year corneal graft survival in the Cornea Donor Study.
INTRODUCTION
The Cornea Donor Study (CDS) recently published results demonstrating no difference in corneal graft survival at 5 years related to donor age. 1 Although eye banks routinely gather information on both the donor and the quality of the corneal tissue before distributing tissue for transplantation, relatively little information is present in the literature concerning the impact of these factors on graft survival. 2 In the CDS, information on cornea donors, tissue handling, and tissue findings was obtained and assessed to examine any potential impact on graft survival at 5 years. The results of these analyses are presented here.
MATERIALS AND METHODS

Study Protocol
Details of the CDS protocol have been reported previously 1, 3, 4 and the key aspects are briefly summarized. The study protocol was approved by Institutional Review Boards for each eye bank and at each investigational site.
Eligible subjects were between 40 and 80 years old and had corneal disease associated with endothelial dysfunction and moderate risk of failure (principally Fuchs dystrophy and pseudophakic corneal edema). Written informed consent was obtained from each subject.
Eligible donor corneas met Eye Bank Association of America standards for human corneal transplantation. 5, 6 Eligibility criteria for the donor corneas assigned in the study are listed in Table 1 . Eye banks obtained information about the cornea donor, including age, gender, race, history of diabetes, and cause of death from medical records, healthcare provider interviews, and family members. Type of tissue recovery, either as whole eye (enucleation) or corneoscleral rim removal (in situ), time from death to placement in preservative medium, body refrigeration time, and death to surgery time were recorded. Specific characteristics of the donor tissue were recorded, including epithelial slit lamp findings, stromal edema, arcus, folds in Descemet's membrane, the presence of ''snail tracks'' (linear ruptures of endothelial cells), and endothelial morphology by specular microscopy.
Clinical investigators and subjects were masked to all characteristics of the donor cornea, including age and endothelial cell density. Preoperative management, surgical technique, and postoperative care (including prescription of medications) were provided according to each investigator's customary routine. The visit schedule during the first 6 postoperative months was at the discretion of the investigator. Thereafter, the minimum follow-up visit schedule included a visit between 6 and 12 months and then annual visits through 5 years. Because of the trial's simple design, data collection at each visit was limited and included an assessment of graft clarity, signs of graft rejection, and intraocular pressure. The definition of graft failure, based on the definition used in the Collaborative Corneal Transplantation Studies, 7,8 was a regraft or, in the absence of regraft, a cloudy cornea in which there was loss of central graft clarity sufficient to compromise vision for a minimum of 3 consecutive months. Further details of the classification scheme for graft failures has been published. 1 
Statistical Methods
The analysis included the 1090 eligible subjects in the CDS. Baseline endothelial cell density was evaluated by the Reading Center for 658 cases. Donor race/ethnicity was excluded from the analysis as a result of the small number of subjects per group (41 blacks, 11 Hispanics, 3 Asians, and 11 other).
Cumulative probabilities of graft failure (subsequently referred to as ''graft failure rates'') were calculated using the Kaplan-Meier method. Univariate Cox proportional hazards regression models were used to individually assess the association of each donor factor with graft failure. No significant deviations from the proportional hazards assumptions were detected.
All reported P values are 2-sided. Because of multiple comparisons, P values $0.01 were not considered statistically significant. Statistical analyses were conducted using SAS version 9.1 software (SAS Institute Inc., Cary, NC).
RESULTS
The donor characteristics and slit lamp characteristics of the corneas have been reported in detail previously. 3 The distribution of each characteristic is indicated in Table 2 .
Among the 135 eyes with graft failures, 102 (76%) had a regraft and 33 (24%) met the cloudy cornea failure criteria defined for the study without a regraft (30 had a cloudy cornea for at least 3 months and 3 had a cloudy cornea for less than 3 months without additional available follow up). Three graft failures were the result of primary donor failure, 8 uncorrectable refractive error, 48 graft rejection, 46 endothelial decompensation, and 30 other causes.
As shown in Table 2 , graft failure rates were not significantly impacted by any donor characteristics (gender, history of diabetes, or cause of death); by any factors related to the type of tissue retrieval, processing, timing of use of the cornea (time from death to preservation or time from death to surgery); or by any characteristics of the donor cornea (presence of endothelial polymorphism, endothelial cell damage, Descemet folds, snail tracks, baseline endothelial cell density, epithelial defects, epithelial haze, epithelial exposure, stromal edema, or arcus). Adjusting for donor age did not affect the results (data not shown). When analyses were conducted separately for rejection and nonrejection graft failures, no baseline donor factors were found to be associated with the rate of graft failure based on our prespecified level of significance (data not shown).
DISCUSSION
Although a number of factors evaluated here have been assessed in other studies, this prospective study is one of the few to address their impact on graft survival. The limitation of this study is that the tissue selection criteria excluded extremes such as prolonged death to preservation time and death to surgery time. Only mild to moderate epithelial, stromal, Descemet, and endothelial variations were accepted. Nonetheless, the information obtained is useful in demonstrating the lack of any adverse impact of the abnormalities found in the ranges studied.
Data on donor cause of death and presence or absence of diabetes mellitus show no impact on 5-year graft outcomes. Earlier studies have shown a similar lack of impact of donor cause of death on 5-year graft survival. 2 Recently, deaths resulting from cancer have been implicated in postoperative endophthalmitis, 9 but there were no cases of endophthalmitis attributable to the donor cornea in the CDS. Additional studies have shown no reason to exclude donors with cancer, 10 but these did not look at graft survival. Graft outcome did not differ by method of tissue procurement (enucleation versus in situ retrieval). Rootman and coinvestigators reported no difference in initial donor tissue quality rating by procurement methodology, but they did not look at graft outcomes beyond primary graft failure. 11 A recent study showed no difference in graft clarity at 3 months with either procurement method. 12 Timing of tissue procurement, refrigeration, and use has been studied in the past and has also been shown, within limited ranges, to have no effect on graft outcome, 2 although prolonged storage times, not studied here, may well have a deleterious effect. 13 Endothelial characteristics likewise had no impact on graft outcomes using the donor criteria of the CDS. 14 Epithelial and stromal changes were generally mild with only one case of severe epithelial exposure and one with moderate stromal edema. Although over half of the donor corneas had epithelial defects, these all involved less than 50% of the epithelium and had no statistically significant effect. Because of the relatively low prevalence of endothelial trauma related to tissue preparation, as manifested by snail tracks in the central cornea and present in only 7% of donor corneas, the impact of this type of trauma cannot be fully assessed.
Although study of more extreme alterations of tissue would be of benefit, this study demonstrates effectively, as have the other reports from the CDS, that all tissue meeting the donor criteria used performs equally well. Continued follow up of this cohort through 10 years is ongoing to assess any potential differences in longer-term survival.
